Pacira BioSciences PCRX
NASDAQ PCRX
$36.39 +0.06 (+0.17%)
As of: Oct 22, 2026 · 10:00 AM EDT

Pacira BioSciences (PCRX) Short-Term Debt repayments (2025 - 2026)

Updated

Pacira BioSciences' Short-Term Debt repayments came in at $5 million for Q2 2026, unchanged from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Short-Term Debt repayments (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Pacira BioSciences reported Short-Term Debt repayments of $20 million; for FY2025, it was $10 million.

  • Business Quant data shows PCRX's Short-Term Debt repayments at $5 million (Q1 2026), $5 million (Q4 2025) and $5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn -
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn 6.45 Bn
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn -
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn -
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn -
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn -
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn -
10 Pacira BioSciences 1.44 Bn 498.05 Mn 148.24 Mn 5.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.00 Mn
Mar 31, 2026 5.00 Mn
Dec 31, 2025 5.00 Mn
Sep 30, 2025 5.00 Mn
API Access

Pacira BioSciences Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=PCRX&period=max&api_key=YOUR_API_KEY